Available to SourceCellular Therapy
NDC 71287-0119-02
Yescarta (Axicabtagene Ciloleucel)
Package · 1 BAG in 1 PACKAGE (71287-119-02) / 68 mL in 1 BAG
2000000 1/68mL · Suspension
By Kite Pharma, Inc.
Axicabtagene Ciloleucel · Suspension · 2000000 1/68mL · IV
- NDC
- 71287-0119-02
- Route
- Intravenous
- Therapeutic class
- CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor , CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells , Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]
- Marketing category
- BLA
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a Quote
Request this medication.
Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
